About 153 results

ALLMedicine™ Opsoclonus-myoclonus Syndrome Center

Research & Reviews  59 results

Breast cancer-associated opsoclonus-myoclonus syndrome: a case report.
World Journal of Surgical Oncology; Kostoglou A, Vlastos D et. al.

Nov 17th, 2021 - Paraneoplastic neurological syndromes constitute rare neurological complications of malignant disease, manifesting in <1% of patients with cancer. Opsoclonus-myoclonus syndrome (OMS) presents with chaotic ocular saccades (opsoclonus), spontaneous ...

Post-COVID-19 opsoclonus-myoclonus syndrome and encephalopathy associated with leucine-...
Journal of the Neurological Sciences; Smyth D, Kyaw KM et. al.

Sep 21st, 2021 - Post-COVID-19 opsoclonus-myoclonus syndrome and encephalopathy associated with leucine-rich glioma-inactivated 1 (LGI-1) antibodies.|2021|Smyth D,Kyaw KM,Legister A,MacFarlane G,Sankar UU,|complications,

Atypical Presentation of Enterovirus D68 Infection as Opsoclonus-Myoclonus Syndrome.
Pediatric Neurology; Martin MJ, Rose SC

Sep 12th, 2021 - Atypical Presentation of Enterovirus D68 Infection as Opsoclonus-Myoclonus Syndrome.|2021|Martin MJ,Rose SC,|

Delayed Opsoclonus-Myoclonus Syndrome After Ovarian Teratoma Resection.
Journal of Neuro-ophthalmology : the Official Journal of ... Jones AA, Chen T

Aug 22nd, 2021 - Opsoclonus-myoclonus syndrome (OMS) is a rare syndrome characterized by opsoclonus, which is irregular, spontaneous, multivectorial saccadic eye movements, along with diffuse or focal myoclonus and sometimes ataxia. OMS is associated with paraneop...

see more →

Clinicaltrials.gov  1 results

Study of Cytokines in Children With Opsoclonus-Myoclonus Syndrome

May 23rd, 2017 - In this translational research, immunological mechanisms that underlie the assault of the immune system on the brain in paraneoplastic opsoclonus-myoclonus syndrome (OMS) are under evaluation. To test our principal hypothesis that there is an imba...

see more →

News  1 results

New Registry Offers Insight Into Opsoclonus-Myoclonus Syndrome
Heidi Splete

Oct 23rd, 2018 - WASHINGTON – Ataxia is the most common symptom at disease onset in patients with opsoclonus-myoclonus syndrome (OMS), a rare disease affecting only 1 in 5,000,000 individuals, mostly aged 1-5 years, based on data from a new patient registry. In pa.

see more →